Social Forum >> Forum Thread
Last Price Today's Change   Day's Range   Trading Volume
4.07   -0.15 (3.55%)  4.07 - 4.29  10,250,800
9,620 comment(s). Last comment by mita29 at Jan 19, 2021 6:36 PM
 15 people like this.
 Post Reply   Back  

853 posts

Posted by Apple1234 > Nov 10, 2020 5:50 PM | Report Abuse

Supersinginvestor (无常): may i ask how your case?

141 posts

Posted by Kossan > Nov 10, 2020 8:49 PM | Report Abuse


141 posts

Posted by Kossan > Nov 10, 2020 8:50 PM | Report Abuse

Unlucky margin call to some big timers. With this news, pretty sure a V shape rebound Tomorrow.

3215 posts

Posted by ks5S > Nov 10, 2020 8:57 PM | Report Abuse

serious growth. Will enter klci index soon.
epf will support

418 posts

Posted by antidebt > Nov 10, 2020 9:18 PM | Report Abuse

smart investor will accumulate

3215 posts

Posted by ks5S > Nov 10, 2020 10:48 PM | Report Abuse

kossan smart. announce high profit after budget.
if not , have to donate more.

3215 posts

Posted by ks5S > Nov 10, 2020 11:08 PM | Report Abuse

tomorrow kossan panic buy

1635 posts

Posted by greedy44444 > Nov 10, 2020 11:25 PM | Report Abuse

Who already catched the falling knife ? Tomorrow continue the catch.

1006 posts

Posted by menort > Nov 11, 2020 12:10 AM | Report Abuse

What US trying to say is To lift Joe Biden up need to make their citizen feel happy. So they make story the same story as Ol Putin vaccine. Everyone in vaccine industry know to make vaccine and distribute need such a long time test trial. Make politician good story but with complicated to execute.

Before Putin vaccine announcement russia case was only 300 cases per day and today after Putin vaccine announcement 21k case per day. Suppose with vaccine case should drop to below ten case per day in Russia.

433 posts

Posted by Mtrade > Nov 11, 2020 12:39 AM | Report Abuse


433 posts

Posted by Mtrade > Nov 11, 2020 12:40 AM | Report Abuse

Pfizer got severe side effects

5451 posts

Posted by joyvest > Nov 11, 2020 7:20 AM | Report Abuse

It causes no concern to me.kosan is an established company with worldwide networking of dealership and distributorship. It doesn't need to boost its profit using ASP. Its easily justified by its high volumes of sales

260 posts

Posted by Goku88 > Nov 11, 2020 8:44 AM | Report Abuse

Today Kossan shall rebound! Kossan will fly high with 600% strong net profit results

1111 posts

Posted by Jokers2020 > Nov 11, 2020 8:51 AM | Report Abuse

S. Korea issues avian flu warning after H5N8 found in wild birds

260 posts

Posted by Goku88 > Nov 11, 2020 9:00 AM | Report Abuse

I believe we shall see a very very strong rebound from Kossan soon...

260 posts

Posted by Goku88 > Nov 11, 2020 9:08 AM | Report Abuse

Kossan + Supermx will fly

260 posts

Posted by Goku88 > Nov 11, 2020 9:11 AM | Report Abuse

Kossan + Supermx will fly, trust me

260 posts

Posted by Goku88 > Nov 11, 2020 9:14 AM | Report Abuse

James buy call Kossan https://www.youtube.com/watch?v=vl1N4-E_pE4&t=892s

3215 posts

Posted by ks5S > Nov 11, 2020 9:16 AM | Report Abuse

600% profit company you don't buy but chase those kaput company.
Super dumb.

990 posts

Posted by Seeyounoup > Nov 11, 2020 9:28 AM | Report Abuse

Buy . even the doctor who inject vaccine need to wear glove .

170 posts

Posted by New994 > Nov 11, 2020 9:39 AM | Report Abuse

fantastic result, yesterday sell due to sentiment.

880 posts

Posted by gloveharicut > Nov 11, 2020 10:36 AM | Report Abuse


309 posts

Posted by abc123_2020 > Nov 11, 2020 12:11 PM | Report Abuse

AT will annouce Glove Production any time from now..go go go AT..TP 6 month RM2.00 enough.

880 posts

Posted by gloveharicut > Nov 11, 2020 12:33 PM | Report Abuse


3215 posts

Posted by ks5S > Nov 11, 2020 12:42 PM | Report Abuse


this pfizer ceo is a cheater. Announce news to sell his share.
not sure the pfizer vaccine can pakai or not.

260 posts

Posted by Goku88 > Nov 11, 2020 12:48 PM | Report Abuse

Confirm conman just to make money, vaccine confirm cannot pakai.

3215 posts

Posted by ks5S > Nov 11, 2020 1:10 PM | Report Abuse

after u inject pfizer vaccine, u feel like floating on the air. Just like taken weed

3215 posts

Posted by ks5S > Nov 11, 2020 1:11 PM | Report Abuse

pfizer vaccine use weed as ingredient
painless and make u happy and laughing

3215 posts

Posted by ks5S > Nov 11, 2020 1:17 PM | Report Abuse

fark... usa reported 200k covid cases yesterday. like this glove menang loh

3215 posts

Posted by ks5S > Nov 11, 2020 1:30 PM | Report Abuse

no wonder this pfizer ceo say the vaccine have to store at -80 deg c bcos he is sure this vaccine cannot work.

3215 posts

Posted by ks5S > Nov 11, 2020 1:30 PM | Report Abuse

he cabut first loh

141 posts

Posted by Kossan > Nov 11, 2020 4:03 PM | Report Abuse


1945 posts

Posted by meistsk3134 > Nov 11, 2020 4:04 PM | Report Abuse

dry ais can

23 posts

Posted by Ukga > Nov 11, 2020 6:46 PM | Report Abuse



Some information regarding vaccine development. Enjoy reading and make up your own mind on gloves counters going forward.
A rewarding year for all those who own gloves counters. Cheers..

203 posts

Posted by kd88 > Nov 11, 2020 8:17 PM | Report Abuse


COVID 19会不会成为第2个被人类消灭的病毒?如果会,要用多少年?天花,用了差不多200年。


516 posts

Posted by witan > Nov 11, 2020 8:31 PM | Report Abuse

Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial


Dont make sense. Why would the CEO of Pfizer sold most of his shares?

Unless he knows something we dont know. No confidence in his own vaccine perhaps??

375 posts

Posted by Abilakh > Nov 12, 2020 8:03 AM | Report Abuse


375 posts

Posted by Abilakh > Nov 12, 2020 8:04 AM | Report Abuse


375 posts

Posted by Abilakh > Nov 12, 2020 8:04 AM | Report Abuse


375 posts

Posted by Abilakh > Nov 12, 2020 8:05 AM | Report Abuse


1635 posts

Posted by greedy44444 > Nov 12, 2020 8:31 AM | Report Abuse

Moderna Inc said on Wednesday it has enough data for a first interim analysis of the late-stage trial of its experimental COVID-19 vaccine, which should help determine the vaccine's efficacy.

Moderna said the information is being prepared for submission to the trial's independent data safety monitoring board, which will look at the results and make a recommendation. It did not say when it plans to release the efficacy data.

The company said in a news release that it has seen a significant increase in the number of COVID-19 cases among trial participants as infection rates have surged around the United States.

Due to the spike in cases, the analysis will cover substantially more than 53 infections, which had been the targeted trigger point for the first analysis.

The company said the trial remains blinded, so neither it nor study investigators know which participants received the vaccine or a placebo. The vaccine will be deemed a success if the overwhelming majority of those infected had received a placebo, once the monitoring board looks at the early results.

Earlier in the day, Dr. Anthony Fauci, the top U.S. infectious disease expert, said Moderna could have the data from anywhere between "a couple of days" to "a little more than a week."

A high degree of effectiveness would make sense as it is "almost identical" to Pfizer Inc's experimental vaccine, Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said at a conference organized by the Financial Times.

"It may not be 95%, it might be 90%, or 96%, or 89%, but it is going to be up there," he said.

Pfizer on Monday said its COVID-19 vaccine was more than 90% effective based on interim trial results, significantly higher than the at least 50% efficacy regulators are looking for.

Moderna, which uses a similar messenger RNA technology as Pfizer, said earlier on Wednesday that its November timeline for initial data was on track.

It did not respond to a Reuters request for comment on when it would disclose the data.

The company would still have to wait for two-month follow-up safety data required by the U.S. Food and Drug Administration, which it expects to have in the second half of this month, before applying for U.S. emergency use authorization.

There are no vaccines that have gained global approval yet, although a handful, including Moderna's, are in late-stage studies.

Moderna's shares closed up 8.4% at $82.44 and rose to $83.85 in extended trading

Another vaccine results coming out soon. Beware to all glove lover and shareholders.

516 posts

Posted by witan > Nov 12, 2020 8:40 AM | Report Abuse

Deep-Freeze Hurdle Makes Pfizer’s Vaccine One for the Rich


Sorry guys vaccine wont be available anytime soon

In fact Pfizer share price already start dropping 2 days in a row

7 posts

Posted by plimplam > Nov 12, 2020 8:54 AM | Report Abuse

EPF about to dump Kossan. Good times are over. SELL SELL SELL Macha - get out now!!!

260 posts

Posted by Goku88 > Nov 12, 2020 8:57 AM | Report Abuse

EPF everyday also buy and sell any other stocks, who cares bout EPF anyway. Major countries in EU lockdown and US reported all time high Covid-19 cases yesterday. Buy while price still cheap before too late :)

72 posts

Posted by Passivereturn > Nov 12, 2020 10:31 AM | Report Abuse

Harta and Topglove is in FTSE100. Kossan plan to be in the FTSE100 too. Kossan had increase revenue+profit every quarter. Its PE is below 20 now. Price RM6.56 (as per now) / EPS of 0.4736, the PE is only 13.85. The next 4 quarter the revenue will be about the same or more based on current global demand of gloves. Forget about short term, this stock is for medium term. This company at this price you dont buy, then what do you buy?

45 posts

Posted by lmhkevin > Nov 12, 2020 11:13 AM | Report Abuse

EPF dump at lost? haha... they will dump other counters and then top up again in Gloves

91 posts

Posted by biba > Nov 12, 2020 3:52 PM | Report Abuse

ASPs to drop even as glove demand stays up post-pandemic — AmInvestment Bank
KUALA LUMPUR (Nov 12): AmInvestment Bank believes that while glove demand will stay stable post-Covid-19 pandemic, average selling prices (ASPs) will drop as there will no longer be a rush for gloves.
We reckon that ASP will stabilise at a higher level than pre-pandemic level due to the broader usage of gloves,” it said in a note on Top Glove Corp Bhd today.

The research house’s analyst Thong Pak Leng said it believed that glove demand will remain strong, based on reasons outlined by Top Glove during a webinar, which include a higher awareness of personal hygiene and broader use of gloves beyond the healthcare sector.
In addition, Thong said there may not be an oversupply of gloves after the pandemic, as Top Glove had pointed out that there are key issues in ramping up supply that need to be addressed, including the availability of contractors to build production lines, the shortage of foreign workers and constraint of nitrile raw material.

Top Glove has also allocated 30% of its capacity for spot orders. “The spot orders for nitrile glove have been fully sold for the next three months. Meanwhile, the spot orders for natural rubber powder-free gloves are also increasing due to the long lead time of nitrile gloves,” said Thong.
Presently, Top Glove has a total production capacity of 90 billion pieces per annum.

To expand further, Top Glove has allocated capital expenditure of RM10 billion over the next five years for capacity expansion to double its current capacity by the end of 2025, said Thong. This will be done in stages whereby 14 billion pieces will be added for FY21 and 16 billion for FY22.

AmInvestment Bank maintains its "hold" call on the stock with a lower fair value of RM7.88, adding that the group’s fundamentals remain solid for the next few years.
“We maintain our view that Top Glove’s net profit will peak in FY21 as demand soars from the Covid-19 pandemic with increased capacity expansions. We make no changes to our FY21–FY23 net profit forecasts at RM6.5 billion, RM2.3 billion and RM2.2 billion respectively.
“Our ASP assumptions are US$60 per 1,000 pieces for FY21, US$35 per 1,000 pieces for FY22 and US$28 per 1,000 pieces for FY23 with an average utilisation rate of more than 80%,” said Thong.
Top Glove is currently fourth on Bursa’s top losers list, having fallen 19 sen or 2.42% to RM7.67. The stock is currently valued at RM62.34 billion.

1086 posts

Posted by JohnFarmer458 > Nov 12, 2020 5:59 PM | Report Abuse

Good news to Malaysian Glove producers that has been having shortage of labor

Govt to ‘regularise’ undocumented foreign workers, subject to conditions
FMT Reporters -November 12, 2020 1:21 PM

PETALING JAYA: The government will implement a plan to “regularlise” undocumented migrant workers so they they can become legalised foreign workers subject to certain conditions.

Home Minister Hamzah Zainudin said that under the programme, known as the Undocumented Migrant Recalibration Plan, undocumented migrants will also be allowed to return home voluntarily.

He said the plan, to come into effect from Monday until June 30, 2021, is to address the undocumented migrants issue.

“This plan will be implemented by the Immigration Department and the Department of Labour of Peninsular Malaysia and other government agencies without the involvement of third parties and vendors,” he said at a press conference today.


1635 posts

Posted by greedy44444 > Nov 13, 2020 12:54 AM | Report Abuse

No joy for glove stocks... most penny and speculative stocks went up. Tomorrow it's oil and gas stocks. Get ready for the big bucks. Forget about glove stocks.

10924 posts

Posted by Mabel > Nov 13, 2020 12:55 AM | Report Abuse

I suppose those that sell their Gloves shares are really a pussy..

Mabel will hold the remaining Fantastic Four shares and will grow with these companies ..

Anyway current holding is FOC..


 Post Reply   Back  
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate

457  576  569  492 

Top 10 Active Counters
 VSOLAR 0.040.00 
 SAMAIDEN 1.72+0.04 
 PNEPCB 0.34-0.04 
 PA 0.1750.00 
 CYPARK 1.38+0.04 
 ARBB 0.29+0.015 
 KTG 0.265-0.005 
 QES 0.335-0.02 
 CONNECT 0.2250.00 
 SUNZEN 0.235+0.015 


1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!